SCHEMBL22798993

SCHEMBL22798993

CCOC(=O)Cn1cc(C=NO)c2cc(Cl)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.53
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ CRHBP P24387 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ GAA P10253 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ MAPK8 P45983 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ PTGDR2 Q9Y5Y4 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22798992 1.00 ALDH1A1 (0.53) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL22813793 1.00 ALDH1A1 (0.53) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL19233819 0.87 ALDH1A1 (0.70) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL22798572 0.86 ALDH1A1 (0.53) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL22798571 0.86 ALDH1A1 (0.53) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL22813769 0.86 ALDH1A1 (0.53) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL1120408 0.74 LMNA (0.46) ALDH1A1MAPTHPGDTSHRKMT2A
SCHEMBL22798889 0.73 ALDH1A1 (0.70) ALDH1A1MAPTKMT2AMEN1L3MBTL1
SCHEMBL12481284 0.72 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1LMNAPOLB
SCHEMBL22798772 0.72 PDE4B (0.48) ALDH1A1MAPTHPGDTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753560-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-12-23 — — EP disclosed
Send feedback